Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ApoA-I and ApoB levels, and ApoB-to-ApoA-I ratio as candidate pre-treatment biomarkers of pathomorphological response to neoadjuvant therapy in gastric and esophago-gastric junction adenocarcinoma.
Pol Przegl Chir. 2023 Sep 20;96(2):44-49. doi: 10.5604/01.3001.0053.8925.
Pol Przegl Chir. 2023.
PMID: 38629280
Free article.
Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis.
Nurczyk K, Nowak N, Carlson R, Skoczylas T, Wallner G.
Nurczyk K, et al. Among authors: nowak n.
Adv Med Sci. 2023 Mar;68(1):138-146. doi: 10.1016/j.advms.2023.02.005. Epub 2023 Mar 20.
Adv Med Sci. 2023.
PMID: 36944288
Review.
Item in Clipboard
COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave.
Nurczyk K, Chan CE, Nowak N, Skoczylas T.
Nurczyk K, et al. Among authors: nowak n.
Curr Oncol. 2021 Mar 27;28(2):1348-1353. doi: 10.3390/curroncol28020128.
Curr Oncol. 2021.
PMID: 33801652
Free PMC article.
Item in Clipboard
Cite
Cite